Lesley Kahl

1.4k total citations · 1 hit paper
30 papers, 1.1k citations indexed

About

Lesley Kahl is a scholar working on Infectious Diseases, Virology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lesley Kahl has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 10 papers in Virology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lesley Kahl's work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (10 papers) and Research on Leishmaniasis Studies (8 papers). Lesley Kahl is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (10 papers) and Research on Leishmaniasis Studies (8 papers). Lesley Kahl collaborates with scholars based in United Kingdom, United States and France. Lesley Kahl's co-authors include Brian Wynne, Foo Y. Liew, Kati Vandermeulen, Diane McMahon‐Pratt, Martin Gartland, W. Robert McMaster, Neil F. Fairweather, Linda L. Button, Dong Yang and Michael Aboud and has published in prestigious journals such as The Lancet, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

Lesley Kahl

29 papers receiving 1.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies

2018 243 citations Josep M. Llibre, Chien‐Ching Hung et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lesley Kahl United Kingdom	18	522	316	290	276	170	30	1.1k
Michael Baier Germany	22	479 0.9×	316 1.0×	244 0.8×	393 1.4×	219 1.3×	74	1.4k
O. Patey France	19	534 1.0×	212 0.7×	173 0.6×	364 1.3×	121 0.7×	69	1.2k
Elizabeth S. Machado Brazil	21	660 1.3×	508 1.6×	266 0.9×	388 1.4×	309 1.8×	65	1.3k
Catherine F. Decker United States	19	403 0.8×	153 0.5×	84 0.3×	387 1.4×	95 0.6×	74	1.1k
Anthony Allworth Australia	21	610 1.2×	178 0.6×	418 1.4×	739 2.7×	189 1.1×	34	1.6k
Mohamed Tarek M. Shata United States	28	595 1.1×	268 0.8×	132 0.5×	894 3.2×	499 2.9×	77	2.3k
Chusana Suankratay Thailand	18	309 0.6×	131 0.4×	253 0.9×	457 1.7×	193 1.1×	77	1.2k
J Huisman Netherlands	17	436 0.8×	393 1.2×	74 0.3×	272 1.0×	178 1.0×	46	972
Tomohiko Koibuchi Japan	19	333 0.6×	322 1.0×	64 0.2×	334 1.2×	299 1.8×	56	950
Lindi Masson South Africa	23	362 0.7×	293 0.9×	165 0.6×	584 2.1×	490 2.9×	48	1.6k

Countries citing papers authored by Lesley Kahl

Since Specialization

Citations

This map shows the geographic impact of Lesley Kahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley Kahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley Kahl more than expected).

Fields of papers citing papers by Lesley Kahl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lesley Kahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley Kahl. The network helps show where Lesley Kahl may publish in the future.

Co-authorship network of co-authors of Lesley Kahl

This figure shows the co-authorship network connecting the top 25 collaborators of Lesley Kahl. A scholar is included among the top collaborators of Lesley Kahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lesley Kahl. Lesley Kahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Underwood, Mark, José Castillo‐Mancilla, Lesley Kahl, et al.. (2025). Phase 1 Evaluation of VH4524184, a Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile. Clinical Infectious Diseases. 81(3). 510–520.

Mehta, Rashmi, Konstantinos Angelis, Lesley Kahl, et al.. (2023). Pharmacokinetic and pharmacokinetic/pharmacodynamic characterization of the dolutegravir/rilpivirine two‐drug regimen in SWORD‐1/‐2 phase 3 studies. British Journal of Clinical Pharmacology. 89(7). 2190–2200. 2 indexed citations

Benn, Paul, Ying Zhang, Lesley Kahl, et al.. (2023). A phase I, first‐in‐human study investigating the safety, tolerability, and pharmacokinetics of the maturation inhibitor GSK3739937. Pharmacology Research & Perspectives. 11(3). e01093–e01093. 7 indexed citations

Aboud, Michael, Chloe Orkin, Daniel Podzamczer, et al.. (2019). Efficacy and safety of dolutegravir–rilpivirine for maintenance of virological suppression in adults with HIV-1: 100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studies. The Lancet HIV. 6(9). e576–e587. 77 indexed citations

Llibre, Josep M., Chien‐Ching Hung, Cynthia Brinson, et al.. (2018). Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies. The Lancet. 391(10123). 839–849. 243 indexed citations breakdown →

Walmsley, Sharon, Gary Richmond, Fritz Bredeek, et al.. (2017). Sword 1 and 2: Subgroup Analysis of 48 Week Results by Age, Race and Gender. Open Forum Infectious Diseases. 4(suppl_1). S427–S427. 1 indexed citations

McComsey, Grace A., Sergio Lupo, Lesley Kahl, et al.. (2017). Switch from tenofovir disoproxil fumarate combination to dolutegravir with rilpivirine improves parameters of bone health. AIDS. 32(4). 477–485. 43 indexed citations

Christie, Jason D., Steven N. Vaslef, Philip K.‐Y. Chang, et al.. (2015). A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome. Critical Care Medicine. 43(9). 1859–1869. 29 indexed citations

Flood, Emuella, Kathleen Beusterien, Mayur M. Amonkar, et al.. (2008). Patient and caregiver perspective on pediatric eosinophilic esophagitis and newly developed symptom questionnaires. Current Medical Research and Opinion. 24(12). 3369–3381. 31 indexed citations

10.

Béné, Marie C., Lesley Kahl, H. F. M. Hermes, et al.. (1993). Bacterial Lysates and Ribosomes as Inducers of Specific Immune Responses: a Comparative Study. Scandinavian Journal of Immunology. 38(5). 496–498. 18 indexed citations

11.

Kahl, Lesley, J. E. Byram, John R. David, Sarah A. Comerford, & Franz von Lichtenberg. (1991). Leishmania (Viannia) Braziliensis: Comparative Pathology of Golden Hamsters Infected with Isolates from Cutaneous and Mucosal Lesions of Patients Residing in Tres Bracos, Bahia, Brazil. American Journal of Tropical Medicine and Hygiene. 44(2). 218–232. 20 indexed citations

12.

Rivas, Luís, Lesley Kahl, Kelledy Manson, & Diane McMahon‐Pratt. (1991). Biochemical characterization of the protective membrane glycoprotein GP46/M-2 of Leishmania amazonensis. Molecular and Biochemical Parasitology. 47(2). 235–243. 15 indexed citations

13.

Yang, Dong, Neil F. Fairweather, Linda L. Button, et al.. (1990). Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis.. The Journal of Immunology. 145(7). 2281–2285. 160 indexed citations

14.

Kahl, Lesley, J. E. Byram, & John R. David. (1990). Leishmania (Viannia) braziliensis isolated from cutaneous and mucosal lesions of patients residing in Tres Bracos, Bahia, Brazil differ in virulence for the golden hamster. Transactions of the Royal Society of Tropical Medicine and Hygiene. 84(6). 783–784. 7 indexed citations

15.

Lelchuk, Rosalia, Martin Carrier, Lesley Kahl, & Foo Y. Liew. (1989). Distinct IL-3 activation profile induced by intravenous versus subcutaneous routes of immunization. Cellular Immunology. 122(2). 338–349. 10 indexed citations

16.

Kahl, Lesley, Connor A. P. Scott, Rosalia Lelchuk, Gregory Gregoriadis, & F Y Liew. (1989). Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization.. The Journal of Immunology. 142(12). 4441–4449. 49 indexed citations

17.

Croft, Simon L., Christopher Dye, & Lesley Kahl. (1988). Leishmaniasis: The first centenary (1885–1985) new strategies for control. Parasitology Today. 4(2). 51–53. 20 indexed citations

18.

Kahl, Lesley & Diane McMahon‐Pratt. (1987). Structural and antigenic characterization of a species- and promastigote-specific Leishmania mexicana amazonensis membrane protein.. The Journal of Immunology. 138(5). 1587–1595. 48 indexed citations

19.

Kahl, Lesley, Robin F. Anders, B.J. Rodwell, Peter Timms, & Graham F. Mitchell. (1982). Variable and common antigens of Babesia bovis parasites differing in strain and virulence.. The Journal of Immunology. 129(4). 1700–1705. 41 indexed citations

20.

Mitchell, Graham F., Robin F. Anders, Graham V. Brown, et al.. (1982). Analysis of Infection Characteristics and Antiparasite Immune Responses in Resistant Compared with Susceptible Hosts. Immunological Reviews. 61(1). 137–188. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact